Evidence map›Paper›PMID 34426789›Full record

Observational studyJournal of diabetes research2021

Evaluation of Medical Care for Diabetic and Hypertensive Patients in Primary Care in Mexico: Observational Retrospective Study.

Agustin Lara-Esqueda, Sergio A Zaizar-Fregoso, Violeta M Madrigal-Perez, Mario Ramirez-Flores, Daniel A Montes-Galindo, Margarita L Martinez-Fierro, Iram P Rodriguez-Sanchez, José Guzman-Esquivel, Carmen Meza-Robles, Gabriel Ceja-Espiritu and 9 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Journal of diabetes research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Agustin Lara-EsquedaDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Sergio A Zaizar-FregosoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Violeta M Madrigal-PerezDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Mario Ramirez-FloresDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Daniel A Montes-GalindoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Margarita L Martinez-FierroMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Zacatecas Autonomous University, Zacatecas 98160, Mexico.
Iram P Rodriguez-SanchezMolecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo León, Monterrey, Nuevo León 64460, Mexico.
José Guzman-EsquivelDepartment of Research, Mexican Social Security Institute, Villa de Alvarez, Colima 28983, Mexico.
Carmen Meza-RoblesDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Gabriel Ceja-EspirituDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Pablo A Kuri-MoralesSchool of Medicine, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, 04510, Mexico.
Josuel Delgado-EncisoFundación para la Etica, Education e Investigación del Cáncer del Instituto Estatal de Cancerologia de Colima, Colima 28085, Mexico.
Armando Barriguete-MelendezUniversidad Anahuac Ciudad de Mexico, Mexico.
Hector R Galvan-SalazarDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Carlos E Barajas-SaucedoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Elvin Guillermo-EspinosaColima State Health Services, Colima 28085, Mexico.
Agustin D Lara-BasultoDepartment of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Jesus F Gonzalez-RoldanSubsecretaria de Prevención y Promoción de la Salud, Secretaria de Salud de Mexico, Ciudad de Mexico, 06600, Mexico.
Ivan Delgado-EncisoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID https://orcid.org/0000-0001-9848-862X
Universidad de Colima · MXMexican Social Security Institute · MXSecretaria de Salud · MXUniversidad Anáhuac · MXUniversidad Autónoma de Nuevo León · MXUniversidad Autónoma de Zacatecas "Francisco García Salinas" · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe present study evaluated the quality of medical care for patients diagnosed with diabetes mellitus (DM), hypertension (HBP), and both pathologies (DM+HBP) within a public health system in Mexico.

methods45,498 patients were included from 2012 to 2015. All information was taken from the electronic medical record database. Each patient record was compared against the standard to test the quality of medical care.

resultsGlycemia with hypertension goals reached 29.6% in DM+HBP, 48.6% in DM, and 53.2% in HBP. The goals of serum lipids were reached by 3% in DM+HBP, 5% in DM, and 0.2% in HBP. Glycemia, hypertension, and LDL cholesterol reached 0.04%. 15% of patients had an undiagnosed disease. Clinical follow-up examinations reached 20% for foot examination and clinical eye examination. Specialty referrals reached 1% in angiology or cardiology.

conclusionGoals for glycemic and hypertension reached 50% in the overall population, while serum lipids, clinical follow-up examinations, and referral to a specialist were deficient. Patients who had both diseases had more consultations, better control for hypertension and lipids, but inferior glycemic control. Overall, quality care for DM and/or HBP has not been met according to the standards.

Indexed as

Glycemic ControlPrimary Health CareQuality Indicators, Health CareAdultAgedAntihypertensive AgentsBiomarkersBlood GlucoseBlood PressureDiabetes MellitusDiet, HealthyFemaleHumansHypertensionHypoglycemic AgentsHypolipidemic AgentsAntihypertensive AgentsBiomarkersBlood GlucoseHypoglycemic AgentsHypolipidemic AgentsLipids

Identifiers

PMID34426789
PMCPMC8380161
OpenAlexW3193378820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.